Conference Proceedings

An Australasian Bone Marrow Transplant Registry (ABMTR) Study of the Trends and Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Hodgkin Lymphoma between 2009-2019: Relapse Remains the Most Common Cause of Death Post Transplantation

Kirsty M Sharplin, David Ritchie, David Gottlieb, Ian Bilmon, Shyam Panicker, Glen A Kennedy, Cameron Curley, Duncan Purtill, Julian Cooney, Richard Doocey, Leanne Berkahn, Sam Milliken, Pietro R Di Ciaccio, Peter G Bardy, Andrew Spencer, David J Curtis, Sushrut S Patil, Stephen R Larsen, Travis Perera, Andrew Butler Show all

Blood | American Society of Hematology | Published : 2020

Abstract

An Australasian Bone Marrow Transplant Registry (ABMTR) Study of the Trends and Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Hodgkin Lymphoma between 2009-2019: Relapse remains the most common cause of death post transplantation Introduction: Hodgkin Lymphoma (HL) is an eminently curable disease, with 80% of cases achieving cure with first line therapies. There are a subset of patients who relapse and require salvage therapy including autologous stem cell transplant and more recently novel agents such as brentuximab vedotin (BV) and the PD-1 inhibitors. The latter are less toxic and achieve durable responses but are not considered cu..

View full abstract